Psychedelic Consultation & harm reduction Psychedelics have been cautiously viewed as a treatment for mental health conditions e.g. depression, anxiety and substance use disorders. There are numerous clinical studies showing the effects of certain psychedelics in mental health conditions. Methyl​enedioxy​methamphetamine (MDMA) is going though the process of FDA clearance soon and it might be the first psychedelic to be used for treatment of PTSD in clinical setting. The clinical data has been promising to allow using psychedelics in conjunction with conventional treatment or maybe as a substitution for those who failed conventional treatments. The psychedelic consultation and harm reduction sessions are focused on contents of prior psychedelic experiences. We usually implement these sessions along with our integrated psychotherapy and medication management sessions for those who interested in trying psychedelic for self-growth and improvement in existential distress.

**Please note that we do NOT offer any Psychedelic-Assisted sessions in our practice, as most of those substances are not FDA approved for clinical setting, and are still in research process, and may be used in clinical setting in the future.